Skip to main content
Explore URMC

menu

Comparison of Study Drug and Entiviyo on the treatment of Colitis

Research Question:
Is the study drug comparable or better at treating colitis than Entiviyo (Vedolizumab)

Basic Study Information

Purpose:
Study participation will last just under a year. Subjects will be randomized to receive different dosages of either the study drug or Vedolizumab or placebo. Subjects are required to visit the clinic 13 times for study related procedures. Infusions (IV hookup) is the method for receiving the study drug.

Location: Strong Memorial Hospital
Study Reference #: 20181346

Lead Researcher (Principal Investigator)

Lead Researcher: Lawrence Saubermann

Study Contact Information

Study Coordinator: Lauren Ott
Phone: (585) 276-3042

Additional Study Details

Study Details:
Study sponsored by Genentech, Inc.

Number of Visits:  More than 10
Parking:  Reimbursed
Transportation Coverage: 
Reimbursement:  Yes

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search